Samsamikor, Maryam
Mackay, Dylan
Mollard, Rebecca C.
Aluko, Rotimi E. http://orcid.org/0000-0002-9025-2513
Funding for this research was provided by:
Heart and Stroke Foundation of Canada (G-16-00014211)
Article History
Received: 28 October 2019
Accepted: 12 February 2020
First Online: 23 April 2020
Ethics approval and consent to participate
: This study was reviewed and approved by the Bannatyne REB of the University of Manitoba on 19 December 2016 with the approval number HS20390 (B2016:125). Written informed consent form will be obtained at an in-person screening day from all of the potential participants.Also, the present study was reviewed and approved by the NNHPD of Health Canada on 20 February 2018 with the protocol number HEMP BP 001. In addition, this study was reviewed and approved by the Heart and Stroke Foundation of Canada as the original funding source (Grant #: G-16-00014211). This study is also registered on the publicly accessible Clinical Trial Registry Databank at ClinicalTrials.gov on 28 June 2018 under the number ExternalRef removed (ExternalRef removed).
: Not applicable
: The authors declare that they have no competing interests.